dextrothyroxine has been researched along with Congenital Zika Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksić, MM; Ivković, B; Kotur-Stevuljević, J; Rupar, J; Selaković, M | 1 |
| Basu, U; Daunert, S; Deo, S; Dhar, S; Jayaweera, DT; Kamran, MZ; Kolishetti, N; Shah, AS; Surnar, B | 1 |
| Jans, DA; Wagstaff, KM | 1 |
| Ketkar, H; Wang, P; Wormser, GP; Yang, L | 1 |
1 review(s) available for dextrothyroxine and Congenital Zika Syndrome
| Article | Year |
|---|---|
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Topics: Animals; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Dengue; Dengue Virus; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
3 other study(ies) available for dextrothyroxine and Congenital Zika Syndrome
| Article | Year |
|---|---|
Electrochemical Characterisation and Confirmation of Antioxidative Properties of Ivermectin in Biological Medium.
Topics: Anthelmintics; Antioxidants; Carbon; COVID-19; Electrodes; Humans; Ivermectin; Oxidation-Reduction; SARS-CoV-2; Zika Virus; Zika Virus Infection | 2023 |
Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus.
Topics: Administration, Oral; Animals; Biodegradable Plastics; Drug Delivery Systems; Humans; Ivermectin; Mice; Nanoparticles; Zika Virus; Zika Virus Infection | 2019 |
Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Drug Administration Schedule; Ivermectin; Mice; Mice, Knockout; Treatment Failure; Vero Cells; Zika Virus; Zika Virus Infection | 2019 |